LEXICON PHARMACEUTICALS, INC. Inventory, Raw Materials, Gross
LEXICON PHARMACEUTICALS, INC. (LXRX) had Inventory, Raw Materials, Gross of $0 as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Inventory, Gross
us-gaap:InventoryRawMaterials · last filed 2023-11-08
- 2023-09-30: Inventory, Raw Materials, Gross $0.00.
- 2023-06-30: Inventory, Raw Materials, Gross $0.00.
- 2022-12-31: Inventory, Raw Materials, Gross $0.00.
- 2020-06-30: Inventory, Raw Materials, Gross $1.15M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-04 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-08 | |
| 2020-06-30 | $1.15M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $2.22M 10-Q · filed 2020-04-27 | |
| 2019-12-31 | $3.20M 10-K · filed 2021-03-12 | $3.18M 10-K · filed 2020-03-12 |
| 2019-09-30 | $3.23M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.53M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $3.57M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $3.56M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $3.60M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $961.00K 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $617.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $616.00K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $734.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $200.00K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $200.00K 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |